86 related articles for article (PubMed ID: 8128199)
1. [Endocrine tumors of the pancreas: immunohistochemical and clinical correlation].
Berney C; Kurt AM; Kapanci Y
Schweiz Med Wochenschr; 1994 Feb; 124(5):179-85. PubMed ID: 8128199
[TBL] [Abstract][Full Text] [Related]
2. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix.
Yajima N; Wada R; Yamagishi S; Mizukami H; Itabashi C; Yagihashi S
Hum Pathol; 2005 Nov; 36(11):1217-25. PubMed ID: 16260276
[TBL] [Abstract][Full Text] [Related]
6. [The functionally inactive endocrine pancreas tumor].
Meyer D; Engemann R; Marx A; Thiede A
Chirurg; 1994 Oct; 65(10):856-60. PubMed ID: 7821044
[TBL] [Abstract][Full Text] [Related]
7. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
9. CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival.
Deschamps L; Handra-Luca A; O'Toole D; Sauvanet A; Ruszniewski P; Belghiti J; Bedossa P; Couvelard A
Hum Pathol; 2006 Jul; 37(7):802-8. PubMed ID: 16784978
[TBL] [Abstract][Full Text] [Related]
10. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein in pancreatic endocrine neoplasms.
Tomita T
Mod Pathol; 2000 Apr; 13(4):389-95. PubMed ID: 10786804
[TBL] [Abstract][Full Text] [Related]
12. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in malignant pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M
Cancer Detect Prev; 2000; 24(6):572-8. PubMed ID: 11198271
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
[TBL] [Abstract][Full Text] [Related]
15. Cellular composition and anatomic distribution in nonfunctioning pancreatic endocrine tumors: immunohistochemical study of 30 cases.
Zheng X; Guo K; Tian Y; Li J; Guo R; Zhan Y; Song M; Shen K
Chin Med J (Engl); 1998 Apr; 111(4):373-6. PubMed ID: 10374408
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
[TBL] [Abstract][Full Text] [Related]
17. [Endocrine tumors of the pancreas at a Mexican institution].
Canto Jairala JA; Herrera MF; Gamboa-Domínguez A; Angeles-Angeles A; Uscanga L; Robles-Díaz G; Rull JA; Campuzano M
Rev Invest Clin; 1997; 49(1):25-30. PubMed ID: 9229752
[TBL] [Abstract][Full Text] [Related]
18. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
19. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
